Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2023-08-27 Proxy Solicitation & In…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
祥生医疗关于召开2023年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for convening the 2023 second extraordinary general meeting of shareholders of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting date, voting methods, agenda items, and procedural instructions. The key agenda includes a proposal for a share repurchase plan. The document is a formal announcement about the meeting and voting process, not the actual voting results or minutes. It is not a full financial report, earnings release, or management discussion. It fits the category of a shareholder meeting notice, which aligns with the definition of Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the meeting.
2023-08-27 Chinese
祥生医疗独立董事关于第三届董事会第一次会议相关议案的独立意见
Regulatory Filings
2023-08-27 Chinese
祥生医疗第三届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the first meeting of the third board of directors of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the election of the board chairman, appointment of various committees, and senior management appointments. It also includes a proposal for a share repurchase plan to be submitted to the shareholders' meeting. The content focuses on board and management changes and decisions, not on financial results, audit opinions, or shareholder voting results. The document length is 2157 characters, which is relatively short and typical for a board/management announcement. Therefore, the document fits best under the category of Board/Management Information (MANG).
2023-08-27 Chinese
祥生医疗第三届监事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolution from the first meeting of the third Supervisory Board of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the election of the chairman of the Supervisory Board and includes the chairman's resume. There is no financial data, no mention of annual or interim reports, no audit information, and no regulatory certifications. The content focuses on board/management information, specifically the election of a supervisory board chairman, which fits the category of Board/Management Information (MANG). The document length is short and it is a formal announcement of a board-related decision, not a report or presentation.
2023-08-27 Chinese
祥生医疗2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the company's 2023 first extraordinary general meeting of shareholders. It details the meeting date, attendance, voting results for board and supervisory board elections, and legal compliance statements. There is no financial data or report content, only voting results and meeting procedural information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2023-08-27 Chinese
祥生医疗关于收到控股股东提议回购公司股份的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding a proposal from the controlling shareholder to repurchase company shares. It details the proposal's background, purpose, terms, and risk warnings. The text focuses on the intention and plan for share repurchase, including the amount, price, and usage of repurchased shares. There are no financial statements, earnings data, or detailed financial analysis present. The document is an announcement about a capital action (share repurchase) rather than a report or detailed financial disclosure. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short and does not indicate it is a report publication announcement or regulatory filing. Hence, the classification is CAP with high confidence.
2023-08-21 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.